Systematic review with meta‐analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2015-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/apt.13227PMID 25913530
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-Predominant Irritable Bowel Syndrome Based on Rome III Criteria.

  2015influential reference
• National Institute for Health and Care Excellence.

  2015cited by this paper
• Crosstalk at the mucosal border: importance of the gut microenvironment in IBS

  2015cited by this paper
• The epidemiology of irritable bowel syndrome

  2014cited by this paper
• The quest for biomarkers in IBS—where should it lead us?

  2014cited by this paper
• American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome.

  2014cited by this paper
• Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS

  2014influential reference
• Systematic review: the perceptions, diagnosis and management of irritable bowel syndrome in primary care – A Rome Foundation Working Team Report

  2014cited by this paper
• Screening for bile acid diarrhoea in suspected irritable bowel syndrome

  2014cited by this paper
• Review article: the economic impact of the irritable bowel syndrome

  2014cited by this paper
• Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: a randomized, double-blind, placebo-controlled study.

  2014cited by this paper
• Validating biomarkers of treatable mechanisms in irritable bowel syndrome

  2014influential reference
• Advances in understanding of bile acid diarrhea

  2014cited by this paper
• Systematic review: the management of chronic diarrhoea due to bile acid malabsorption

  2014cited by this paper
• Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles

  2014cited by this paper
• Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.

  2013cited by this paper
• Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment.

  2013cited by this paper
• SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.

  2013cited by this paper
• Recycling rate of bile acids in the enterohepatic recirculation as a major determinant of whole body 75SeHCAT retention

  2013cited by this paper
• PTU-180 Bile Acid Diarrhoea – the Good, the Bad and Equivocal Responders: a two Centre Comparison

  2013cited by this paper
• Methods for diagnosis of bile acid malabsorption in clinical practice.

  2013cited by this paper
• Coronary Heart Disease Statistics 2012

  2012cited by this paper
• Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

  2012cited by this paper
• Systematic review of diagnostic criteria for IBS demonstrates poor validity and utilization of Rome III

  2012cited by this paper
• Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.

  2012cited by this paper
• Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea

  2012influential reference
• QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

  2011cited by this paper
• Post‐infectious irritable bowel syndrome: The past, the present and the future

  2011cited by this paper
• Bile acid malabsorption: An under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms

  2011influential reference
• Applicability of the reported prevalence of bile salt malabsorption in irritable bowel

  2010cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea‐predominant irritable bowel syndrome

  2009influential reference
• Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis.

  2009cited by this paper
• Recent advances in the understanding of bile acid malabsorption.

  2009cited by this paper
• Coronary heart disease statistics.

  2008cited by this paper
• Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study.

  2007influential reference
• ROME III: The Functional Gastrointestinal Disorders

  2007cited by this paper
• An Introduction to Metaanalysis

  2005cited by this paper
• Irritable bowel syndrome.

  2004cited by this paper
• Coronary Heart Disease

  2002cited by this paper
• Enterohepatic Circulation

  2002cited by this paper
• Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care.

  2001cited by this paper
• Bile Acid Malabsorption in Persistent Diarrhoea

  2000cited by this paper
• Predictive value of the rome criteria for diagnosing the irritable bowel syndrome

  1999cited by this paper
• The functional gastrointestinal disorders

  1997cited by this paper
• Idiopathic bile acid malabsorption--a review of clinical presentation, diagnosis, and response to treatment.

  1991cited by this paper
• [Irritable bowel syndrome].

  1988cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Coronary heart disease

  1957influential reference

• Practices, Attitudes, Perceived Knowledge, and Intentions Underlying Low‐Fat Dietary Behaviours in Adults Living With Bile Acid Diarrhoea: A Cross‐Sectional Study

  2026cites this paper
• Microbially produced bile acids are associated with increased IgG autoantibodies and poorer mental wellbeing in fibromyalgia

  2026cites this paper
• Chronic, Noninfectious Diarrhea: A Review.

  2026cites this paper
• Bile acid malabsorption (BAM): A rarely suspected cause of chronic diarrhea - Towards an efficient and economic diagnosis.

  2025cites this paper
• European Consensus on Malabsorption—UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN

  2025cites this paper
• Common misconceptions and controversies in the management of irritable bowel syndrome

  2025influential citation
• Serum 7αC4 as a pragmatic diagnostic tool for bile acid malabsorption in Mexico: Implications and future directions.

  2025cites this paper
• Dietary modifications in patients with non-inflammatory bowel disease diarrhoea: a summary of the evidence and practical considerations

  2025influential citation
• Management of bile acid diarrhea in Italy: a survey

  2025influential citation
• El 7αC4 sérico como herramienta diagnóstica práctica para la mala absorción de ácido biliar en México: implicaciones y direcciones futuras

  2025cites this paper
• Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024.

  2025cites this paper
• Simplifying Diagnosis of Bile Acid Diarrhea with Clinical and Biochemical Measurements on Blood and Single Stool Sample.

  2025cites this paper
• Gut microbial dysbiosis associated to diarrheic irritable bowel syndrome can be efficiently simulated in the Mucosal ARtificial COLon (M-ARCOL)

  2025cites this paper
• Respuesta a Rattanapitoon et al., «El 7αC4 sérico como herramienta diagnóstica pragmática para la malabsorción de ácidos biliares en México: implicaciones y perspectivas futuras»

  2025cites this paper
• Real-world experience with the diagnosis of bile acid malabsorption (BAM) using serum 7-alpha-C4 and 48-hour stool bile acids.

  2025cites this paper
• The Impact of Hangeshashinto on Symptoms and Gut Microbiota in Diarrhea-type Irritable Bowel Syndrome: A Retrospective Analysis

  2025cites this paper
• Mala absorción de ácidos biliares (MAAB): una causa pocas veces sospechada de diarrea crónica. Hacia un diagnóstico eficiente y económico

  2025cites this paper
• An evidence-based update on the diagnosis and management of irritable bowel syndrome

  2025cites this paper
• Tratamiento farmacológico del síndrome de intestino irritable en México. Posicionamiento de la Asociación Mexicana de Gastroenterología 2024

  2025cites this paper
• Bile acid diarrhea in patients with chronic diarrhea. Current appraisal and recommendations for clinical practice.

  2025cites this paper
• Global prevalence and gastrointestinal symptom burden of individuals with a history of cholecystectomy

  2025cites this paper
• Exploration of TCM Comprehensive Treatment of Irritable Bowel Syndrome Based on Pathophysiological Mechanism

  2025cites this paper
• Response to Rattanapitoon et al., "Serum 7αC4 as a pragmatic diagnostic tool for bile acid malabsorption in Mexico: Implications and future directions".

  2025cites this paper
• The Analysis of Volleyball Learning and Its Impact on Physical Fitness: A Longitudinal Review of Speed, Strength, and Flexibility in the Perspective of the Sport Pedagogy Approach to Physical and Health Education

  2025cites this paper
• Assessment of the triglyceride glucose index in adult patients with chronic diarrhea and constipation

  2024cites this paper
• Journal of Clinical Gastroenterology Lectureship Dubai 2022

  2024cites this paper
• The function of the gut microbiota–bile acid–TGR5 axis in diarrhea-predominant irritable bowel syndrome

  2024cites this paper
• 담즙산 설사

  2024cites this paper
• Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care

  2024cites this paper
• Prevalence and determinants of postprandial diarrhea in a tertiary care center

  2024cites this paper
• Microbiome Shifts and Their Impact on Gut Physiology in Irritable Bowel Syndrome

  2024cites this paper
• Experiencia en la vida real con el diagnóstico de malabsorción de ácidos biliares (MAAB) utilizando 7-alfa-C4 sérico y ácidos biliares en heces de 48 horas

  2024cites this paper
• Determination of Bile Acids in Canine Biological Samples: Diagnostic Significance

  2024cites this paper
• Development and validation of a novel 7α-hydroxy-4-cholesten-3-one (C4) liquid chromatography tandem mass spectrometry method and its utility to assess pre-analytical stability

  2024cites this paper
• The alteration of mucosal bile acid profile is associated with nerve growth factor expression in mast cells and bowel symptoms in diarrhea-predominant irritable bowel syndrome.

  2024cites this paper
• Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden

  2024cites this paper
• Advances in the pathophysiology, diagnosis and management of chronic diarrhoea from bile acid malabsorption: a systematic review.

  2024cites this paper
• Comparison between SeHCAT test and clinical response to cholestyramine in patients with chronic diarrhea and high suspicion of bile acid malabsorption: A single‐center prospective study

  2024cites this paper
• Bile acid malabsorption investigated by selenium-75-homocholic acid taurine (75SeHCAT) scans, a retrospective single-centre experience.

  2024cites this paper
• The Role of Gut Microbiome in Irritable Bowel Syndrome: Implications for Clinical Therapeutics

  2024cites this paper
• Mucosa-Associated Microbiota Dysbiosis in the Terminal Ileum Correlates With Bowel Symptoms in Diarrhea-Predominant Irritable Bowel Syndrome

  2023cites this paper
• Food intolerance related to gastrointestinal symptoms amongst adults living with bile acid diarrhoea: A cross-sectional study.

  2023cites this paper
• Development of functional gastrointestinal disorder symptoms following laparoscopic cholecystectomy: a prospective cohort study

  2023cites this paper
• Diagnosis of Irritable Bowel Syndrome: Primary Care Physicians Compared with Gastroenterologists

  2023cites this paper
• Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome

  2023cites this paper
• A Diagnosis of Irritable Bowel Syndrome Using Rome IV Criteria and Limited Investigations is Durable in Secondary Care.

  2023cites this paper
• Emerging uses of glucagon-like peptide 1 (GLP-1) receptor agonists following ileal resection: literature review and case examples

  2023cites this paper
• The neurobiology of irritable bowel syndrome

  2023cites this paper
• Bio-Analytical Method Development and Validation of Asciminib and its Application to Pharmacokinetic Studies in Rat Plasma by Using RP-HPLC

  2023cites this paper
• Biomarkers for Bile Acid Malabsorption in Diarrhea-predominant Irritable Bowel Syndrome

  2023cites this paper
• Fecal microbiota transplantation for treatment of irritable bowel syndrome: Current advances and future perspectives

  2023cites this paper
• Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome

  2023cites this paper
• Primer consenso centroamericano y del Caribe del síndrome de intestino irritable

  2023cites this paper
• Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities

  2022cites this paper
• Pathophysiology and Clinical Management of Bile Acid Diarrhea

  2022cites this paper
• Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility

  2022cites this paper
• Effectiveness of diet, psychological, and exercise therapies for the management of bile acid diarrhoea in adults: A systematic review

  2022cites this paper
• Chologene Diarrhö, Stiefkind der chronischen Diarrhö – Prävalenz, Diagnostik und Therapie

  2022cites this paper
• Belgian consensus on irritable bowel syndrome.

  2022cites this paper
• SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis

  2022cites this paper
• Diagnostic yield of colonoscopy for organic disease in irritable bowel syndrome and its risk factors: A meta‐analysis

  2022cites this paper
• Bile acids, bioactive signalling molecules in interoceptive gut‐to‐brain communication

  2022cites this paper
• Up-to-Date Diagnosis and Management of IBS and Chronic Constipation in Primary Care.

  2021cites this paper
• Differential mRNA Expression in Ileal Mucosal Biopsies of Patients With Diarrhea- or Constipation-Predominant Irritable Bowel Syndrome

  2021cites this paper
• Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS‐D) and IBS mixed pattern (IBS‐M)

  2021cites this paper
• Review article: Diagnosis and investigation of irritable bowel syndrome

  2021cites this paper
• Irritable bowel syndrome

  2021cites this paper
• Die chologene Diarrhö - Diagnose statt Probetherapie

  2021cites this paper
• Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021

  2021cites this paper
• Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms

  2021cites this paper
• The gut virome in Irritable Bowel Syndrome differs from that of controls

  2021influential citation
• Bacillus Subtilis Promotes the Release of 5-HT to Regulate Intestinal Peristalsis in STC Mice via Bile Acid and Its Receptor TGR5 Pathway

  2021cites this paper
• Functional Disorders After Colorectal Surgery/IBS

  2021cites this paper
• Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids

  2021cites this paper
• Longitudinal follow‐up of a novel classification system for irritable bowel syndrome: natural history and prognostic value

  2021cites this paper
• Irritable Bowel Syndrome-Strategies for Diagnosis and Management

  2021cites this paper
• High Pressure Liquid Chromatographic Method for the Determination of Mobocertinib in Pharmaceutical Dosage Form and Study of Its Degradation

  2021cites this paper
• Prevalence of biliary acid malabsorption in patients with chronic diarrhoea of functional characteristics: a prospective study

  2021influential citation
• Chologene Diarrhö, Stiefkind der chronischen Diarrhö – Prävalenz, Diagnostik und Therapie. Update 2021

  2021cites this paper
• Endoscopic diagnosis of chronic diarrhea

  2021cites this paper
• Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption

  2021cites this paper
• Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome

  2021cites this paper
• Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome

  2021cites this paper
• Role of antispasmodics in the treatment of irritable bowel syndrome

  2021cites this paper
• British Society of Gastroenterology guidelines on the management of irritable bowel syndrome

  2021cites this paper
• Obesity and functional bowel disorders: are they linked?

  2021cites this paper
• Manipulating the Microbiome: An Alternative Treatment for Bile Acid Diarrhoea

  2021cites this paper
• Faecal bile acids and colonic bile acid membrane receptor correlate with symptom severity of diarrhoea-predominant irritable bowel syndrome: A pilot study.

  2021cites this paper
• Vitamin D ameliorates high-fat-diet-induced hepatic injury via inhibiting pyroptosis and alters gut microbiota in rats.

  2021cites this paper
• Prognosis of patients with Rome IV‐defined versus physician‐diagnosed irritable bowel syndrome: Longitudinal follow‐up study

  2021cites this paper
• Evidence-based clinical practice guidelines for irritable bowel syndrome 2020

  2021cites this paper
• Management of irritable bowel syndrome with diarrhea: focus on eluxadoline

  2021cites this paper
• Functional Bowel Disease.

  2021cites this paper
• The role of bile acids and their TGR5 receptor in irritable bowel syndrome and diarrhoea.

  2021cites this paper
• The patient with irritable bowel syndrome-type symptoms: when to investigate and how?

  2020cites this paper
• Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome

  2020cites this paper
• Bile acid diarrhoea: Current and potential methods of diagnosis

  2020cites this paper
• Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.

  2020cites this paper
• Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care

  2020cites this paper
• High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria

  2020cites this paper